The amount available is subject to adequate legislative appropriation and expenditure authority. The goal of this center should be to bring together basic science and clinical research faculty in multiple fields to enhance the effectiveness of cancer and genetics technology transfer. CRS, at its discretion, reserves the right to fund one or no such centers based upon the scientific merit of the applications as determined by the peer review process.
All amounts listed below are for direct costs only.
Indirect costs may be charged up to 25 percent of the total modified direct costs. This is the award mechanism for investigator initiated projects. Applicants must explain their applications in detail, listing the qualifications of the investigator and describing adequately the general objectives and specific aims of the proposal, the methods of procedure, the significance of the proposed research, the available facilities, and previous related work by other researchers. Applicants must provide a budget estimate with adequate justification of individual items. PFSA funding is intended for applications encompassing developmental, exploratory or pilot research.